OSA-Direct
Monday, 01 Jul 2019

KAIST invests in OLED light therapy research and development

The goal will be to develop a wide range of human body-based phototherapy technologies in the next seven years for use in treating a variety of diseases

17 Aug 2017 | Editor

According to news on the ET NEws and Digitimes websites KAIST has announced they are teaming up with several Korean Government funded research units to develop next-generation OLED light therapy device technology.

The South Korean Institute of Science and Technology (KAIST) will build a wearable medical device with OLED as a light source to replace the existing use of LEDs as a light source and is expected to be used in a variety of disease treatments to redefine the medical market.

According to the news reports, KAIST will work with the Engineering Research Center (ERC) to set up a human body adhesion light treatment engineering centre.

The Centre will conduct technology research and development that aims to treat skin wounds and improve sleep disorders, as well as technologies that prevent and treat dementia and mild cognitive impairment.

The goal will be to develop a wide range of human body-based phototherapy technologies in the next seven years for use in treating a variety of diseases.

According the research centre OLED is currently used mainly for the panel industry, light treatment center will promote the application of medical technology research, medical technology combined with ICT, a model of the era of industry 4.0.

"This technology is expected to break the existing optical treatment market map, because the existing machine inconvenient to carry, so most people are going to the hospital for treatment, and the future device will be portable or wearable, light treatment centre. In 3 to 5 years to show the treatment of wound, sleep disorders research results, then the medical market is expected to appear a new business model, and this technology can also be applied to the field of skin beauty.

Light therapy centre staff